Musella Foundation Awards Grant to Tocagen to Support Clinical Study…

“This grant supports an important new opportunity for patients with Grade 3 glioma,” said Al Musella, DPM, President of the Musella Foundation. “It is innovations like Toca 511 & Toca FC that we...

(PRWeb July 17, 2012)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog